Latest News and Press Releases
Want to stay updated on the latest news?
-
Verizon Board of Directors declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter.
-
CINCINNATI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, announced that...
-
Shareholders as at the ex-dividend date of 12 June 2025 will be eligible to receive any potential special dividend distributions relating to Tembo transactions Corresponding record date will be 13...
-
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Gold Candle Ltd. (Private) (the “Company”) is pleased to announce the appointment of Richard (Rick) Howes as Chief Executive...
-
Strategic diversification into power infrastructure and cryptocurrencies supports long-term biopharma innovation PROVIDENCE, R.I., April 22, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ:...
-
Winter Park, FL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc. (Nasdaq: SRM) (the “Company”) today announced, despite receiving numerous inquiries from investors, SRM Entertainment has...
-
CEO of Tevogen Bio, Dr. Saadi addresses short selling and its potential impact on the nation’s health and prosperity. Reaffirms commitment to shareholders.
-
KULR announced it has increased its bitcoin purchases for its Bitcoin Treasury by an additional $10 million to reach a total of approximately $60 million i
-
WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
-
Key Takeaways: Since its founding in 2020, Tevogen Bio has developed a significant asset portfolio, and kept expenditures under $40 million, a fraction of the industry norm.Tevogen’s success would...